🕵️ Damora Therapeutics, Inc. ($DMRA)
SEC insider & ownership activity, last 12 months · CIK 1800315 · every row links its SEC filing
Over the last 12 months insiders sold $31K with no open-market buying against it. Hans T. Schambye sold $15K in discretionary trades (Jan). 1 planned sale is pending, the largest $193K (Firmani Lori). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 3 sellers, $31K (4 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Hans T. Schambye | 0 | – | 1 | $15K | Jan 2, 2026 |
| Winslow Garrett | 0 | – | 2 | $13K | Jul 6, 2026 |
| Firmani Lori | 0 | – | 1 | $3K | Jan 2, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Fairmount Funds Management LLC | 20.0% | 13D | Feb 9, 2026 | filing ↗ | |
| Tomas Kiselak | 20.0% | 13D | Feb 9, 2026 | filing ↗ | |
| Peter Evan Harwin | 20.0% | 13D | Feb 9, 2026 | filing ↗ | |
| FMR LLC | 15.0% | 13G | Dec 5, 2025 | filing ↗ | |
| Abigail P. Johnson | 15.0% | 13G | Dec 5, 2025 | filing ↗ | |
| Fairmount Healthcare Fund II L.P. | 13.3% | 13D | Feb 9, 2026 | filing ↗ | |
| Fairmount Healthcare Co-Invest V L.P. | 6.7% | 13D | Feb 9, 2026 | filing ↗ | |
| Avoro Capital Advisors LLC | 6.3% | 13G | May 15, 2026 | filing ↗ | |
| Behzad Aghazadeh | 6.3% | 13G | May 15, 2026 | filing ↗ | |
| Venrock Healthcare Capital Partners III, L.P. | 6.0% | 13G | Feb 17, 2026 | filing ↗ | |
| VHCP Co-Investment Holdings III, LLC | 6.0% | 13G | Feb 17, 2026 | filing ↗ | |
| Venrock Healthcare Capital Partners EG, L.P. | 6.0% | 13G | Feb 17, 2026 | filing ↗ | |
| VHCP Management III, LLC | 6.0% | 13G | Feb 17, 2026 | filing ↗ | |
| VHCP Management EG, LLC | 6.0% | 13G | Feb 17, 2026 | filing ↗ | |
| Nimish Shah | 6.0% | 13G | Feb 17, 2026 | filing ↗ | |
| Bong Y. Koh | 6.0% | 13G | Feb 17, 2026 | filing ↗ | |
| Blackrock, Inc. | 5.1% | 13G | Jul 28, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Firmani Lori | $193K | Jun 22, 2026 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jul 16, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Jul 16, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jul 16, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 16, 2026 | filing ↗ |
| Shareholder vote (5.07) | Apr 28, 2026 | filing ↗ |
| Officer/director changes (5.02) | Apr 28, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 28, 2026 | filing ↗ |
| Auditor change (4.01) | Apr 17, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 17, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 20, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 20, 2026 | filing ↗ |
| Earnings (2.02) | Mar 6, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Mar 6, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 6, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 10, 2026 | filing ↗ |
| Officer/director changes (5.02) | Feb 6, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Feb 6, 2026 | filing ↗ |
| Other events (8.01) | Feb 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 6, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jan 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 12, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Dec 31, 2025 | filing ↗ |
| Officer/director changes (5.02) | Dec 31, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Dec 31, 2025 | filing ↗ |
| Charter/bylaw changes (5.03) | Nov 10, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 10, 2025 | filing ↗ |